CALLER IQ
LIVE

Serial Number

99442570

Owner

Foundation Lead Group

Attorney

Amanda V Dwight

First Use Date

Nov 2, 2023

Filing Date

Oct 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CALLER IQ Trademark

Serial Number: 99442570

CALLER IQ is a trademark filed by Foundation Lead Group on October 14, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Foundation Lead Group (5 trademarks)

2121 Alton Pkwy Suite #150
Irvine, CA 92606

Entity Type: 16

Trademark Details

Filing Date

October 14, 2025

Registration Date

Not Registered

First Use Anywhere

November 2, 2023

First Use in Commerce

November 2, 2023

Goods & Services

Software as a service (SAAS) services featuring software using artificial intelligence for tracking, transcribing, summarizing, and analyzing telephone calls, including speech recognition; Software as a service (SAAS) services featuring software using artificial intelligence and machine learning to score telephone calls and to generate analytics and insights regarding call handling, call outcomes, and customer-service performance; Software as a service (SAAS) services featuring software that provides insights and reporting derived from telephone-call analysis for staff training, quality assurance, and improving customer interactions.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 14, 2025 MAFR
NEW APPLICATION ENTERED
Oct 14, 2025 NWAP

Related Trademarks

More in Same Class

MAGIC WEBCAST

MAGIC WEBCAST

3EMOTIONS INNOVATION GROUP logo

3EMOTIONS INNOVATION GROUP

LAMPMARK LEGACY

LAMPMARK LEGACY

Trademark logo

Serial #99442695

EUREKA RUBY MINE

EUREKA RUBY MINE

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.